膀癌中的微RNA:生物发生,功能和治疗策略
Lei Gao1, Jun Chen1, Kun Shang1
1The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, China.
International journal of surgery (London, England)
|November 13, 2025
概括
微RNA通过控制基因表达和免疫反应来调节膀癌. 新型miRNA疗法有前途,但需要进一步研究,以了解复杂的监管网络,以改善精确医学.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 微RNA (miRNA) 是小的非编码RNA,对基因调节至关重要.
- miRNAs显著影响膀癌的发病,进展和转移.
- 了解miRNA的作用对于开发新的膀癌治疗方法至关重要.
研究的目的:
- 在膀癌中系统地审查miRNA生物发生,调节和功能.
- 探索miRNAs对瘤细胞增殖,转移和免疫逃避的影响.
- 讨论目前和未来基于miRNA的治疗策略和挑战.
主要方法:
- 对膀癌中miRNAs的科学文献进行系统审查.
- 分析miRNA调节机制,包括正规和非正规途径.
- 对关键基因 (例如,p21,TAGLN2,PROM2) 的miRNA向和免疫微环境调制的检查.
主要成果:
- 特定的miRNAs抑制了膀癌细胞的增殖和转移.
- miRNAs通过调节T细胞和髓状细胞衍生的抑制细胞,在免疫逃避中发挥作用.
- 基于miRNA的疗法,如替代性和反感性寡核酸,显示出临床潜力.
结论:
- miRNAs是膀癌的关键调节者,影响瘤发生和免疫反应.
- 新兴的miRNA疗法提供了提高化学敏感性和抑制瘤进展的潜力.
- 进一步研究整合多学科和系统生物学对于临床翻译和精准医学至关重要.
相关概念视频
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K


